Dolo 150 mg/1 ml Injection

Manufactured byMicro Labs Ltd.
ContainsParacetamol
OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
PRACTO
COPY CODE
Description

Dolo 150 mg/1 ml Injection is used to temporarily relieve fever and mild to moderate pain such as muscle ache, toothache, and backache. This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects.

Side effects

Major & minor side effects for Dolo 150 mg/1 ml Injection

  • Nausea or Vomiting
  • Allergic skin reaction
  • Bloody and cloudy urine
  • Anemia
  • Fatigue
  • Headache
  • Insomnia

Uses of Dolo 150 mg/1 ml Injection

What is it prescribed for?

  • Fever
  • Muscle Pain
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine can be observed within 15 to 30 minutes of administration of the dose.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 4-6 hours.
  • Safe with alcohol?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious side effects such as severe gastrointestinal bleeding, dizziness, fatigue, weakness, rashes, nausea, joint pain, fever, jaundice, etc.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary and the potential benefits outweigh the risks involved. This medicine is not known to cause any harm to the fetus, but should only be used after consulting with a doctor.
  • Usage while breast-feeding?
    This medicine is safe to use during breastfeeding. However, it is advised to consult your doctor before taking this medicine. Monitoring the infant for any undesired side effects like skin rashes or diarrhea while taking this medicine is advised.

Allergy

This medicine is not recommended for use if you have a known allergy to paracetamol or any other components present along with it.

Analgesic Nephropathy (Kidney Disease)

This medicine is not recommended for use in patients suffering from kidney diseases associated with the excessive use of painkillers.

Severe liver impairment

This medicine is not recommended for use in patients with severe liver diseases due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary and the potential benefits outweigh the risks involved. This medicine is not known to cause any harm to the fetus, but should only be used after consulting with a doctor.

Breast-feeding

This medicine is safe to use during breastfeeding. However, it is advised to consult your doctor before taking this medicine. Monitoring the infant for any undesired side effects like skin rashes or diarrhea while taking this medicine is advised.
General warnings

Liver Disease

This medicine should be used with extreme caution in patients suffering from liver function impairment or active liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Chronic Malnutrition

This medicine should be used with extreme caution in patients suffering from malnourishment due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Skin reactions

This medicine should be used with extreme caution due to the increased risk of skin reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, etc. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Renal impairment

This medicine should be used with caution in patients with a known history of kidney diseases due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Intravenous administration

When used intravenously, this medicine should be infused for a duration of at least 15 minutes.

Missed Dose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of serious side effects such as severe gastrointestinal bleeding, dizziness, fatigue, weakness, rashes, nausea, joint pain, fever, jaundice, etc.
Interaction with Medicine

Carbamazepine

Phenytoin

Sodium Nitrite

Leflunomide

Prilocaine

Isoniazid

Zidovudine

Probenecid

Naltrexone

Disease interactions

Alcoholism

This medicine should be used with extreme caution in patients with liver function impairment or active liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Report any symptoms such as nausea, fever, rashes, dark urine, etc. to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Liver Disease

This medicine should be used with extreme caution in patients with chronic alcohol use due to the increased risk of serious liver injuries. Close monitoring of liver function is recommended for such patients. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions

5-HIAA Urine Test

Use of this medicine may give a false-positive result for this test. It is advised to inform the doctor and lab technician about the consumption of this medicine before the test is performed.
This medicine should be administered by a qualified healthcare professional. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine increases the pain threshold and decreases swelling. It also brings down elevated body temperature by acting on heat regulatory centers in the brain.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Miscellaneous analgesics

Schedule

Schedule H

Acetaminophen | C8H9NO2 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 22 February 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/1983#section=Top

[Internet]. 2017 [cited 23 June 2017]. Available from:

https://davisplus.fadavis.com/3976/meddeck/pdf/acetaminophen.pdf

Acetaminophen: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 22 September 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a681004.html

DailyMed - acetaminophen injection, solution [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 11 April 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5177abd-9465-40d8-861d-3904496d82b7

[Internet]. Accessdata.fda.gov. 2018 [cited 11 April 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204767s000lbl.pdf

[Internet]. Medsafe.govt.nz. 2018 [cited 11 April 2018]. Available from:

http://www.medsafe.govt.nz/Consumers/CMI/p/paracetamolKabi.pdf

[Internet]. Maneeshpharma.com. 2018 [cited 11 April 2018]. Available from:

http://www.maneeshpharma.com/products/Hospital_care_Febrinil.html
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Book a doctor

Chat with verified doctors starting @ ₹99
Book now
Something doesn’t feel right?
Report an error